Advisor Group Holdings, Inc. Clene Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.31 - $0.44 $4,758 - $6,754
15,350 Added 94.46%
31,600 $11,000
Q3 2023

Nov 13, 2023
BUY
$0.46 - $0.87 $5,175 - $9,787
11,250 Added 225.0%
16,250 $8,000
Q2 2021

Aug 02, 2021
BUY
$6.98 - $13.33 $34,900 - $66,650
5,000 New
5,000 $56,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email